Fumonisin $B_1$-induced Alteration of Sphingolipid Metabolism in $LLC-PK_1$ Cells

$LLC-PK_1$ 세포에서의 퓨모너신 $B_1$에 의해 유도된 스핑고리피드 대사

  • 유환수 (충북대학교 약학대학 약학과) ;
  • 윤여표 (충북대학교 약학대학 약학과)
  • Published : 1997.12.01

Abstract

The purpose of this study was to determine the effect of sulfinpyrazone on fumonisin $B_1$-induced elevation of free sphingoid bases in LLC-$PK_1$ cells. Fumonis ins are a family of mycotoxins produced by the fungi Fusarium moniliforme which is common contaminant in corn. Fumonisins are also potent inhibiors of sphingosine and sphinganine N-acyltransferases (ceramide synthases), key enzymes in sphingolipid metabolism resulting in the elevation of free sphinganine. The cytosolic concentration of fumonisin B1 was known to be closely proportional to the elevation of free sphinganine in LLC-PK1 cells [Yoo, H.-S., Norred, W.P., Wang, E., Merrill, A.H., Jr., and Riley, R.T. (1992) Toxicol. Appl.Pharmacol. 114. 9-15]. Sulfinpyrazone, an anion transport inhibitor, reduced the elevated level of free sphinganine resulting from fumonisin B1 inhibition of de novo sphingolipid biosynthesis. Fumonisin B1 at a concentration of 20${\mu}$M showed approximately 120pmol/$10^6$ cells relative to 3-10pmol/$10^6$ cells in control cultures, and sulfinpyrazone at a concentration of 200${\mu}$M partially reversed the increased level of free sphinganine induced by fumonisin $B_1$ down to normal level after exposure to fumonisin $B_1$ for 8 to 24hr. However, the reduced effect of sulfinpyrazone on the fumonisin $B_1$-induced elevation of intracellular sphinganine was not shown after 24hr. Fumonisin $B_1$ exposure to LLC-PK1 cells for 36 and 48hr showed approximately 74 and 80pmol per $10^6$ cells relative to 82 and 76pmol,respectively, in fumonisin $B_1$ plus sulfinpyrazone-treated cultures. Sulfinpyrazone-induced less elevation of free sphinganine in confluent cells after exposure to fumonisin $B_1$ suggested that either sulfinpyrazone may block the availability of fumonisin $B_1$ to cells or act on the fumonisin $B_1$ interaction with ceramide synthase.

References

  1. Toxicol. Appl. Pharmacol. v.114 Fumonisin inhibition of de novo shpingolipid biosynthesis and cytotoxicity are correlated in LLC-PK₁ cells Yoo, H.-S.;Norred, W. P.;Wang, E.;Merrill, A. H., Jr.;Riley, R. T.
  2. Annu. Rev. Phytopathol. v.31 Fumonisins, mycotoxins produced by Fusarium species: biology, chemistry, and significance Nelson, P. E.;Desjardins, A. E.;Plattner, R. D.
  3. J. Chem. Soc. Chem. Commun. Structure elucidation of the fumonisins, mycotoxins from Fusarium moniliforme Bezuidenhout, S. C.;Gelderblom, W. C. A.;Gorst-Allman, C. P.;Horak, R. M.;Marasas, W. F. O.;Spiteller, G.;Vleggaar, R.
  4. Appl. Environ. Microbiol. v.59 Thermostability of fumonisin B₁, a mycotoxin from Fusarium moniliforme, in Corn Dupuy, J.;Le Bars, P.;Boudra, H.;Le Bars, J.
  5. Fd. Chem. Toxic v.20 Initial studies on the toxicokinetics of fumonisin B₁in rats Shephard, G. S.;Thiel, P. G.;Sydenham, E. W.
  6. Mycopathologia v.116 Toxicity of mycotoxins fumonisins B₁ and B₂and Alternaria alternata f. Sp. lycopersici toxin (AAL) in cultured mammalian cells Shier, W. T.;Abbas, H. K.;Microcha, C. J.
  7. Toxicol. Appl. Pharmacol. v.138 Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity Yoo, H.-S.;Norred, W. P.;Showker, J. L.;Riley, R. T.
  8. Onderstepoort J. Vet. Res. v.57 Leukoencephalomalacia in two horses induced by oral dosing of fumonisin B₁ Kellerman, T. S.;Marasas, W. F. O.;Thiel, P. G.;Gelderblo, W. C. A.;Cawood, M.;Coetzer, J. A. W.
  9. Mycopathologia v.117 Characterization of fumonisin toxicity in orally and intravenously dosed swine Haschek, W. M.;Motelin, G. K.;Ness, D. K.;Harlin, K. S.;Hall, W. F.;Vesonder, R. F.;Peterson, R. E.;Beasley, V. R.
  10. Mycopathologia v.126 Temporal and dose-response features in swine fed corn screenings contaminated with fumonisin mycotoxins Motelin, G. K.;Haschek, W. M.;Ness, D. K.;Hall, W. F.;Harlin, K. S.;Schaeffer, D. J.;Beasley, V. R.
  11. Natural Toxins v.1 A Preliminary investigation on renal and hepatic toxicity in rats fed purified fumonisin B₁ Voss, K. A.;Chamberlain, W. J.;Bacon, C. W.;Norred, W. P.
  12. Avian Dis. v.38 Fumonisin mycotoxicosis in broilers. Weights and serum chemistry modifications Espada, Y.;Ruiz de Gopegui, Cuadradas;Cabanes, F. J.
  13. J. Vet. Diagn. Invest. v.6 no.1 Experimental feeding of Fusarium moniliforme culture material containing fumonisin B₁to channel catfish, Ictalurus punctatus Brown, D. W.;McCoy, C. P.;Rottinghaus, G. E.
  14. Atherosclerosis v.94 Atherogenic effects in a non-human primate of Fusarium moniliforme cultures added to a carbohydrate diet Fincham, J. E.;Marasas, W. F. O.;Taljaard, J. J. F.;Kriek, N. P. J.;Badenhorst, C. J.;Gelderblom, W. C. A.;Seier, J. V.;Smuts, C. M.;Faber, M.;Weight, M. J.;Slazus, W.;Woodrof, C. W.;van Wyk, M. J.;Kruger, M.;Thiel, P. G.
  15. Mycopathologia v.117 The implications of naturally occurring levels of fumonisins in corn for human and animal health Thiel, P. G.;Marasas, W. F. O.;Sydenham, E. W.;Shephard, G. S.;Gelderblom, W. C. A.
  16. Science v.243 Functions of sphingolipids and sphingolipid breakdown products in cellular regulation Hannun, Y. A.;Bell, R. M.
  17. J. Biol. Chem. v.261 Inhibition of phorbol ester-dependent differentiation of human promyelocytic leukemic (HL-60) cell by sphinganine and other long-chain bases Merrill, A. H., Jr.;Sereni, A. M.;Stevens, V. L.;Hannun, Y. A.;Bell, R. M.;Kinkade, J. M. Jr.
  18. J. Biol. Chem. v.265 Inhibition of Na^{+}$Na, K^{+}$- ATPase and sodium pump by protein kinase C regulators sphingosine, lysophosp-hatidylcholine, and oleic acid Oishi, K.;Zheng, B.;Kuo, J. F.
  19. J. Biol. Chem. v.269 Sphingosine-1-phosphate generated in the endoplasmic reticulum membrane activates release of stored calcium Ghosh, T. K.;Bian, J.;Gill, D. L.
  20. J. Biol. Chem. v.265 Role of ceramide as a lipid mediator of 1α-25-dihydroxyvitamin D₃-induced cell differentiation Okazaki, T.;Bielawska, R. A.;Bell, R. M.;Hannun, Y. A.
  21. Proc. Natl. Acad. Sci. U.S.A. v.84 Vaccines containing purified GM₂ ganglioside elicit GM₂antibodies in melanoma patients Livingston, P.;Natoli, J. E.;Calves, M. J.;Stockert, E.;Oettgen, H. F.;Old, L. J.
  22. Science v.259 Programmed cell death induced by ceramide Obeid, L. M.;Linardic, C. M.;Karolak, L. A.;Hannun, Y. A.
  23. J. Biochem. Toxicol. v.2 Age and growth related changes in cyclopiazonic acid-potentiated lipophilic cation accumulation by cultured cells and binding to freeze-thaw lysed cells Riley, R. T.;Goeger, D. E.;Showker, J. L.;Cole, R. J.;Doner, J.
  24. Anal. Biochem. v.171 Quantitation of free sphingosine in liver by high-performance liquid chromatography Merrill, A. H., Jr.;Wang, E.;Mullins, R. E.;Jamison, W. C.;Nimkar, S.;Liotta, D. C.
  25. J. Biol. Chem. v.263 Sphinganine effects on chemoattractant-induced diacylglycerol generation, calcium fluxes, superoxide production, and on cell viability in the human neutrophil Lambeth, J. D.;Burnham, D. N.;Tyagi, S. R.
  26. Biochim. Biophys. Acta v.1051 Characteristics of the growth inhibition and cytotoxicity of long-chain (sphingoid) bases for Chinese hamster ovary cells: evidence for an involvement of protein kinases C Stevens, V. L.;Nimkar, S.;Jamison, W. C.;Liotta, D. A.;Merrill, A. H., Jr.
  27. Nature v.380 Calcium mobilization via sphingosine kinase in signalling by the FcεRI antigen receptor Choi, O. H.;Kim, J,-H.;Kinet, J.-P.